Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Change in Cash (2016 - 2025)

KalVista Pharmaceuticals' Change in Cash history spans 10 years, with the latest figure at -$35.7 million for Q2 2025.

  • On a quarterly basis, Change in Cash fell 508.44% to -$35.7 million in Q2 2025 year-over-year; TTM through Apr 2025 was -$17.1 million, a 29.88% increase, with the full-year FY2025 number at $100.5 million, up 510.99% from a year prior.
  • Change in Cash hit -$35.7 million in Q2 2025 for KalVista Pharmaceuticals, down from $9.7 million in the prior quarter.
  • Over the last five years, Change in Cash for KALV hit a ceiling of $9.7 million in Q4 2024 and a floor of -$35.7 million in Q2 2025.
  • Historically, Change in Cash has averaged -$7.2 million across 3 years, with a median of $59000.0 in 2024.
  • Biggest five-year swings in Change in Cash: skyrocketed 100.86% in 2024 and later crashed 508.44% in 2025.
  • Tracing KALV's Change in Cash over 3 years: stood at $8.3 million in 2023, then rose by 17.88% to $9.7 million in 2024, then crashed by 466.47% to -$35.7 million in 2025.
  • Business Quant data shows Change in Cash for KALV at -$35.7 million in Q2 2025, $9.7 million in Q4 2024, and $59000.0 in Q3 2024.